ID

34482

Description

Study to Allow for Second Treatment Cycle of DCVAC in Patients With Localized Prostate Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT02137746

Link

https://clinicaltrials.gov/show/NCT02137746

Keywords

  1. 1/17/19 1/17/19 -
  2. 5/22/19 5/22/19 -
Copyright Holder

see on clinicaltrials.gov

Uploaded on

January 17, 2019

DOI

To request one please log in.

License

Creative Commons BY-NC 3.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Prostate Cancer NCT02137746

Eligibility Prostate Cancer NCT02137746

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
male 18 years and older
Description

ID.1

Data type

boolean

histologically confirmed prostate adenocarcinoma stage pathological tumor-2 (pt2)
Description

ID.2

Data type

boolean

post radical primary prostatectomy
Description

ID.3

Data type

boolean

completion of dcvac/pca arm in study sp003, without objective progression of the disease
Description

ID.4

Data type

boolean

Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
prior androgen deprivation therapy for prostate cancer
Description

ID.5

Data type

boolean

peripheral neuropathy of common toxicity criteria (ctc) grade 2 or greater
Description

ID.6

Data type

boolean

other uncontrolled intercurrent illness
Description

ID.7

Data type

boolean

treatment with immunotherapy against pca
Description

ID.8

Data type

boolean

clinically significant cardiovascular disease
Description

ID.9

Data type

boolean

active autoimmune disease requiring treatment
Description

ID.10

Data type

boolean

Similar models

Eligibility Prostate Cancer NCT02137746

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
male 18 years and older
boolean
ID.2
Item
histologically confirmed prostate adenocarcinoma stage pathological tumor-2 (pt2)
boolean
ID.3
Item
post radical primary prostatectomy
boolean
ID.4
Item
completion of dcvac/pca arm in study sp003, without objective progression of the disease
boolean
Item Group
C0680251 (UMLS CUI)
ID.5
Item
prior androgen deprivation therapy for prostate cancer
boolean
ID.6
Item
peripheral neuropathy of common toxicity criteria (ctc) grade 2 or greater
boolean
ID.7
Item
other uncontrolled intercurrent illness
boolean
ID.8
Item
treatment with immunotherapy against pca
boolean
ID.9
Item
clinically significant cardiovascular disease
boolean
ID.10
Item
active autoimmune disease requiring treatment
boolean

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial